Exploration and Verification of the Therapeutic Mechanism of Shenfu Injection in Sepsis-induced Myocardial Injury

Overview

Journal PLoS One

Date 2025 Jan 17

PMID 39823512

Authors

Hua-Jing Yuan

Guo-Han Xiang

Yang Liu

Yan Li

Wen-Li Liu

Jiu-Xiang Wei

Yi-Tao Xue

Hao Hao

Affiliations

Soon will be listed here.

Abstract

Background: Shenfu injection (SFI), derived from a traditional Chinese medicine (TCM) prescription, is an effective drug for the treatment of sepsis-induced myocardial injury (SIMI) with good efficacy, but its exact therapeutic mechanism remains unclear.

Methods: SwissTargetPrediction and GeneCards database were used to obtain relevant targets for SFI and SIMI. STRING 11.5 and MCODE were used to analyse potential therapeutic targets for SFI. DAVID 6.8 database was used to perform enrichment analysis. In addition, the SIMI model was constructed by cecal ligation and puncture (CLP) on Sprague Dawley rats and the related protein expression levels were verified by AutoDock Vina 1.1.2 and experiment.

Results: SFI has a total of 10 main active compounds and treats SIMI through 52 potential targets, among which LGALS3, STAT3, FGF1, and AKT1 were the core targets for treatment. Based on enrichment analysis, STAT3, FGF1, and AKT1 in the core targets were experimentally validated. The experimental results showed that SFI effectively ameliorated the inflammatory response and myocardial injury and inhibited apoptosis in SIMI. And SFI improved SIMI by decreasing caspase-9, STAT3 and phospho-AKT1 (p-AKT1) expression, and enhancing FGF1 expressions.

Conclusions: This study showed that SFI effectively reduced the expression of caspase-9, STAT3 and p-AKT1, enhanced the expression of FGF1, reduced the inflammatory response, inhibited apoptosis and attenuated cardiac injury to SIMI.

References

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S . The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016; 54:1.30.1-1.30.33. DOI: 10.1002/cpbi.5. View

Di Lorenzo A, Fernandez-Hernando C, Cirino G, Sessa W . Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci U S A. 2009; 106(34):14552-7. PMC: 2732859. DOI: 10.1073/pnas.0904073106. View

Rong J, Pan H, He J, Zhang Y, Hu Y, Wang C . Long non-coding RNA KCNQ1OT1/microRNA-204-5p/LGALS3 axis regulates myocardial ischemia/reperfusion injury in mice. Cell Signal. 2019; 66:109441. DOI: 10.1016/j.cellsig.2019.109441. View

Chen R, Rui Q, Wang Q, Tian F, Wu J, Kong X . Shenfu injection attenuates lipopolysaccharide-induced myocardial inflammation and apoptosis in rats. Chin J Nat Med. 2020; 18(3):226-233. DOI: 10.1016/S1875-5364(20)30025-X. View

Wang X, Guo R, Guo Y, Guo Q, Yan Y, Gong W . Rationale and design of the RESTORE trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI. Am Heart J. 2023; 260:9-17. DOI: 10.1016/j.ahj.2023.02.005. View

Romero-Bermejo F, Ruiz-Bailen M, Gil-Cebrian J, Huertos-Ranchal M . Sepsis-induced cardiomyopathy. Curr Cardiol Rev. 2012; 7(3):163-83. PMC: 3263481. DOI: 10.2174/157340311798220494. View

Hetenyi C, van der Spoel D . Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci. 2002; 11(7):1729-37. PMC: 2373668. DOI: 10.1110/ps.0202302. View

Xu P, Zhang W, Xie J, Wen Y, Zhang G, Lu S . Shenfu injection prevents sepsis-induced myocardial injury by inhibiting mitochondrial apoptosis. J Ethnopharmacol. 2020; 261:113068. DOI: 10.1016/j.jep.2020.113068. View

Huang P, Guo Y, Feng S, Zhao G, Li B, Liu Q . Efficacy and safety of Shenfu injection for septic shock: A systematic review and meta-analysis of randomized controlled trials. Am J Emerg Med. 2019; 37(12):2197-2204. DOI: 10.1016/j.ajem.2019.03.032. View

10.

Shen B, Qu C, Mi L, Wang H, Yang H . Simultaneous quantification of twenty-eight components of Shenfu Injection in rat plasma by UHPLC-QQQ MS and its application to a pharmacokinetic study. J Pharm Biomed Anal. 2021; 203:114211. DOI: 10.1016/j.jpba.2021.114211. View

11.

Ru J, Li P, Wang J, Zhou W, Li B, Huang C . TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014; 6:13. PMC: 4001360. DOI: 10.1186/1758-2946-6-13. View

12.

Zhao L, Jin L, Luo Y, Wang L, Li Y, Xian S . Shenfu injection attenuates cardiac dysfunction and inhibits apoptosis in septic mice. Ann Transl Med. 2022; 10(10):597. PMC: 9201198. DOI: 10.21037/atm-22-836. View

13.

Aneman A, Vieillard-Baron A . Cardiac dysfunction in sepsis. Intensive Care Med. 2016; 42(12):2073-2076. DOI: 10.1007/s00134-016-4503-4. View

14.

Dhlamini Q, Wang W, Feng G, Chen A, Chong L, Li X . FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress. Mol Med. 2022; 28(1):73. PMC: 9238076. DOI: 10.1186/s10020-022-00502-8. View

15.

Li R, Li X, Zhao J, Meng F, Yao C, Bao E . Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation. Theranostics. 2022; 12(2):976-998. PMC: 8692896. DOI: 10.7150/thno.63751. View

16.

Tao L, Mo Z, Li Z, Li S, Luo Z, Li D . Efficacy and Safety of Shenfu Injection on Acute Heart Failure: A Systematic Review and Meta-Analysis. Phytomedicine. 2023; 110:154641. DOI: 10.1016/j.phymed.2023.154641. View

17.

Bommhardt U, Chang K, Swanson P, Wagner T, Tinsley K, Karl I . Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol. 2004; 172(12):7583-91. DOI: 10.4049/jimmunol.172.12.7583. View

18.

Lei W, Liu D, Sun M, Lu C, Yang W, Wang C . Targeting STAT3: A crucial modulator of sepsis. J Cell Physiol. 2021; 236(11):7814-7831. DOI: 10.1002/jcp.30394. View

19.

Xu C, Xia Y, Jia Z, Wang S, Zhao T, Wu L . The curative effect of Shenfu-injection in the treatment of burn sepsis and its effect on the patient's immune function, HMGB, and vWF. Am J Transl Res. 2022; 14(4):2428-2435. PMC: 9091091. View

20.

Li M, Pan C, Wang X, Mo X, Shi Z, Xu J . Effect of the Shenfu Injection Combined with Early Goal-Directed Therapy on Organ Functions and Outcomes of Septic Shock Patients. Cell Biochem Biophys. 2015; 72(3):807-12. DOI: 10.1007/s12013-015-0537-4. View